Tag: US

Fox News Flash top headlines for November 11 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. Secretary of State Antony Blinken said Wednesday the U.S. had negotiated a deal between Johnson & Johnson and the COVAX vaccine-sharing program to distribute the company’s COVID-19 vaccine to people living in conflict zones. In

A plateau in U.S. COVID-19 cases following several weeks of declining infections is a “worrisome” indication for a potential spike this winter as people congregate inside more often because of holidays and colder weather, a Johns Hopkins University expert said Friday. The United States had been reporting case declines of 10 percent or more each

(Reuters) – Deaths and infections related to COVID-19 have declined across the Americas for the eighth consecutive week, the Pan American Health Organization said, adding that a very high percentage of hospitalized cases now were unvaccinated people.FILE PHOTO: People wearing face masks are seen at the Kazansky railway station amid the outbreak of the coronavirus

FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell(Reuters) – The United States has administered 419,020,753 doses of COVID-19 vaccines in the country as of Friday morning and distributed 514,925,015 doses, the U.S. Centers for Disease Control and Prevention said.

(Reuters) – Signs of post-traumatic stress disorder (PTSD) seen in frontline healthcare workers during the COVID-19 pandemic may be linked to trauma that occurred earlier in their lives, according to a study from Oxford University. About three-fourth of the 103 healthcare workers assessed reported a trauma that was unrelated to their work during the pandemic,

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly(Reuters) – Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients access to a novel treatment

FILE PHOTO: Syringes filled with a doses of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermidWASHINGTON (Reuters) – Pfizer Inc and BioNTech have asked U.S. regulators to approve emergency use of their COVID-19

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11—and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German

FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith(Reuters) – U.S. biotech Amgen Inc has made a $100-million equity investment in Neumora Therapeutics, the brain disease drug developer said on Thursday, adding that it will also get global rights to develop and sell

(Reuters) -Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its experimental COVID-19 vaccine that meets regulators’ quality standards, resulting in production delays.FILE PHOTO: A vial and sryinge are seen in front of a displayed Novavax logo in this illustration taken January

FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic(Corrects paragraph 4 RIC of CanSino Biologics) KUALA LUMPUR (Reuters) -Malaysia has granted conditional approval for the COVID-19 vaccine made

FILE PHOTO: New Zealand Prime Minister Jacinda Ardern participates in a televised debate with National leader Judith Collins at TVNZ in Auckland, New Zealand, September 22, 2020. Fiona Goodall/Pool via REUTERS/File PhotoWELLINGTON (Reuters) – New Zealand Prime Minster Jacinda Ardern said on Monday that the country’s biggest city Auckland will remain in lockdown for another

Dr. Siegel: AstraZeneca drug could protect unvaccinated individuals against COVID AstraZeneca seeks U.S. approval for coronavirus drug. Fox News medical contributor Dr. Marc Siegel with insight on ‘Fox & Friends.’ The U.S. is experiencing a decline in daily COVID-19 deaths after a two-month steady increase to mid-September, according to data compiled by the Centers for

COVID’s devastating toll on kids’ mental health not over yet Children’s Hospital Colorado declares a mental health state of emergency; Fox News correspondent Aishah Hasnie reports on the startling statistics. More than 140,000 U.S. children lost a parent, grandparent or other caregiver to COVID-19, a study found, with researchers noting significant racial and ethnic disparities

FILE PHOTO: Vials of coronavirus disease (COVID-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo/File Photo/File Photo(Reuters) -People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from

LONDON (Reuters) – A patchwork of campaigns for an extra COVID-19 shot are being rolled out across the European Union even before the region’s drug watchdog rules on whether they are safe and effective.FILE PHOTO: A health worker prepares a booster dose of a coronavirus disease (COVID-19) vaccine, as vaccinations jump in Italy after the

FILE PHOTO: Vials of Chinese Sinovac’s CoronaVac vaccine against coronavirus disease (COVID-19) pictured inside the newly inaugurated production lab designated to manufacture the vaccine, in Constantine, Algeria September 29, 2021. REUTERS/Ramzi BoudinaKUALA LUMPUR (Reuters) – Malaysia has given conditional approval for a COVID-19 vaccine made by China’s Sinovac to be used on young people aged

FILE PHOTO: A large vaccination site is shown as people with preexisting health conditions are granted access to a vaccination during the outbreak of the coronavirus disease (COVID-19) in Inglewood, California, U.S., March 15, 2021. REUTERS/Mike Blake(Reuters) – The United States has administered 390,664,923 doses of COVID-19 vaccines in the country as of Monday morning

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed a booster shot of the Pfizer/BioNTech COVID-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings. The decision by CDC Director Rochelle Walensky is aligned with the U.S. Food and Drug

Many hopes have been pinned on repurposing existing drugs, such as ivermectin and hydroxychloroquine, to treat COVID-19. However, we shouldn’t be too surprised these drugs haven’t yet lived up to the hype. Our study, published today in Science Translational Medicine, shows it’s notoriously difficult to repurpose existing drugs for new diseases or for new uses.